Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

46.07 +0.27 (+0.59%)

Official Closing Price Updated: 7:00 PM EDT, May 8, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	12,054,051
Open	45.97
Bid (Size)	45.85 (100)
Ask (Size)	46.00 (100)
Prev. Close	45.80
Today's Range	45.19 - 46.14
52wk Range	35.12 - 81.44
Shares Outstanding	N/A
Dividend Yield	5.54%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Is This News From Novo Nordisk a Warning for Eli Lilly Shareholders? ↗

May 09, 2026

The weight loss drug market is on track to reach almost $100 billion.

Via The Motley Fool

Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus ↗

May 08, 2026

As Hims & Hers pivots to branded GLP-1s via a Novo Nordisk deal, all eyes are on the company’s May 11 earnings as investors look for sustained subscriber growth.

Via MarketBeat

Performance

YTD	-12.1%	-12.1%
1 Month	+23.1%	+23.1%
3 Month	-6.7%	-6.7%
6 Month	+0.3%	+0.3%
1 Year	-30.0%	-30.0%

More News

Forget Eli Lilly: These 2 Stocks Have More Upside ↗

May 07, 2026

Via The Motley Fool

What the FDA's Latest Proposal Means for Lilly, Novo, and Hims ↗

May 07, 2026

Via MarketBeat

My Top Obesity Stock to Buy and Hold ↗

May 07, 2026

Via The Motley Fool

Record Highs, Punished Results, and One Very Consequential Apple Rumor ↗

May 06, 2026

Via Chartmill

3 Absurdly Cheap Growth Stocks to Buy in May 2026 ↗

May 04, 2026

Via The Motley Fool

Here's Exactly Why Wall Street Thinks Viking Therapeutics Stock Could Soar 207% Over the Next 12 Months ↗

May 04, 2026

Via The Motley Fool

Eli Lilly Just Announced Fantastic News for Shareholders ↗

May 04, 2026

Via The Motley Fool

Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026) ↗

May 02, 2026

Via The Motley Fool

Lilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It Permanent ↗

May 01, 2026

Via MarketBeat

Viking Therapeutics Faces Timeline Risk—But Upside Could Be Huge ↗

May 01, 2026

Via MarketBeat

What's the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer. ↗

April 30, 2026

Via The Motley Fool

Is Eli Lilly Stock Undervalued at $870? 1 Top Wall Street Analyst Thinks So ↗

April 28, 2026

Via The Motley Fool

Amazon Takes a Bite Out of Hims: What Its GLP-1 Entrance Means ↗

April 28, 2026

Via MarketBeat

Is This Deal a Game Changer for Novo Nordisk? ↗

April 27, 2026

Via The Motley Fool

Forget Weight Loss Drugs: Here's An Even Better Reason to Invest in Eli Lilly ↗

April 27, 2026

Via The Motley Fool

This Obesity Stock Could More Than Double Over the Next 12 Months, According to Wall Street ↗

April 26, 2026

Via The Motley Fool

Is This Tech Giant the Next Potential Winner in the GLP-1 Weight Loss Boom? ↗

April 25, 2026

Via The Motley Fool

Why Eli Lilly Stock Flopped on Friday ↗

April 24, 2026

Via The Motley Fool

Here's Why Agios Pharmaceuticals Stock Slumped This Week (And What Investors Have to Look Forward to in 2026) ↗

April 24, 2026

Via The Motley Fool

Is Novo Nordisk's 72% Crash a Generational Buying Opportunity or a Value Trap? ↗

April 23, 2026

Via The Motley Fool

The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial

April 23, 2026

From Equity Insider

Via GlobeNewswire

Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins ↗

April 23, 2026

Via The Motley Fool

Stock Market Today, April 21: Hims & Hers Health Drops as Amazon Unveils Competing Weight Loss Program ↗

April 21, 2026

Via The Motley Fool

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?

Yes, Novo Nordisk A/S Common Stock is publicly traded.

What exchange does Novo Nordisk A/S Common Stock trade on?

Novo Nordisk A/S Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Novo Nordisk A/S Common Stock?

The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange

What is the current price of Novo Nordisk A/S Common Stock?

The current price of Novo Nordisk A/S Common Stock is 46.07

When was Novo Nordisk A/S Common Stock last traded?

The last trade of Novo Nordisk A/S Common Stock was at 05/08/26 07:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.